NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $57,777,000 | +210.4% | 673 | +201.8% | 0.01% | +150.0% |
Q2 2017 | $18,614,000 | +12.4% | 223 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $16,562,000 | -8.3% | 223 | -10.1% | 0.00% | 0.0% |
Q4 2016 | $18,064,000 | -99.4% | 248 | -99.3% | 0.00% | -99.5% |
Q2 2016 | $3,074,323,000 | +13.0% | 37,260 | -0.8% | 0.39% | +5.7% |
Q1 2016 | $2,720,919,000 | -35.2% | 37,561 | -23.0% | 0.37% | -38.8% |
Q4 2015 | $4,197,720,000 | +30.4% | 48,788 | +42.6% | 0.60% | -11.6% |
Q3 2015 | $3,219,623,000 | +10.6% | 34,204 | +6.4% | 0.68% | +4.5% |
Q2 2015 | $2,911,173,000 | -29.7% | 32,157 | -23.4% | 0.65% | -4.7% |
Q1 2015 | $4,138,662,000 | +76.8% | 41,970 | +66.1% | 0.68% | -9.9% |
Q4 2014 | $2,341,518,000 | -27.3% | 25,270 | -26.1% | 0.76% | +18.3% |
Q3 2014 | $3,219,623,000 | +69.5% | 34,204 | +63.1% | 0.64% | -14.7% |
Q2 2014 | $1,899,048,000 | +32.3% | 20,977 | +24.3% | 0.75% | -10.6% |
Q1 2014 | $1,435,308,000 | +76.8% | 16,882 | +67.2% | 0.84% | +12.3% |
Q4 2013 | $811,677,000 | – | 10,098 | – | 0.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |